OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
September 02, 2020
Early adopters and equipment manufacturers refine their equipment and processes, paving the way for broader use.
August 24, 2020
Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.
August 20, 2020
EC finalizes agreement to purchase millions of doses of AstraZeneca's COVID-19 vaccine.
CARBOGEN AMCIS has announced significant investments to increase manufacturing capacity in Switzerland and France.
Novavax has signed an agreement with the UK government for 60 million doses of a COVID-19 vaccine and a Phase III clinical trial.
August 19, 2020
Plastic primary packaging could help prevent supply chain shortages associated with high demand for COVID-19 vaccines.
July 23, 2020
Fujifilm Diosynth Biotechnologies’ North Carolina site will be used to manufacture Novavax’ NVX‑CoV2373 vaccine candidate for a Phase III clinical trial.
July 21, 2020
Study reports immune and T-cell response from CanSino COVID-19 vaccine candidate.
Preliminary data from a German Phase I/II trial shows Pfizer/BioNTech COVID-19 vaccine candidate produces immune response.
July 20, 2020
Strong immune response by patients receiving two doses of vaccine suggests a possible treatment strategy.